Hepatitis B Vaccine

Collaboration to develop thermostable hepatitis B vaccines announced

Published in Vaccine Weekly, November 30th, 2005

RxKinetix Inc. and Indian Immunologicals Ltd. announced they will collaborate in the development of thermostable hepatitis B vaccines with improved stability at nonrefrigerated temperatures.

This project is funded by a grant awarded to RxKinetix from the foundation for the U.S. National Institutes of Health through the Grand Challenges in Global Health Initiative.

As part of the collaboration, Indian Immunologicals Limited will supply RxKinetix with hepatitis B vaccine, which will be formulated by RxKinetix in its ProJuvant vaccine delivery platform and tested for thermostability. Formulations showing good potential will then be tested in...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2005-11-30)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry